ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716270; 2) Community: the network communities that were significantly associated with the response to NSC 716270; 3) Molecule: the relationships between components within communities and NSC 716270; 4) MDR: the compounds that were significantly associated with the NSC 716270.

NSC Compound Enrichment Correlation
NSC 709564 Null 0.0304779558345021 0.16051721
NSC 118994 Inosine dialdehyde 0.0366216145653018 0.3802707
NSC 638287 Null 0.0366216145653018 0.27404576
NSC 658872 Null 0.0366216145653018 0.38450592
NSC 682817 7,10:11,14-Dietheno-28H-23,27-nitrilo-22H-dibenzo[b,p] [1,18,5,14]dioxadiazacyclopentacosine 0.0366216145653018 -0.26107779
NSC 695636 1-Nonyl-3-(2',6'-dimethyl-3',5'-diethoxycarbonyl-1',4'-dihydropyridyl-4')pyridinium bromide 0.0366216145653018 0.16170897
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0386895225700407 -0.12383378
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0386895225700407 0.21391742
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0386895225700407 0.15226565
NSC 180973 Tamoxifen citrate 0.0386895225700407 0.31735027
Total:77  Current:61    [First] [Prev] [Next] [Last]